At a glance
- Originator Bristol-Myers Squibb
- Class Antithrombotics
- Mechanism of Action Factor Xa inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 23 Sep 1998 New profile
- 23 Sep 1998 Preclinical development for Thrombosis in USA (Unknown route)